that oral oseltamivir or abidol has been used for suspected or confirmed SARS-CoV-2 cases.
Favilavir, formerly known as Fapilavir, was the first anti-novel coronavirus drug that has been approved for marketing by the National Medical Products Administration since the outbreak. The drug was developed by Zhejiang Hisun Pharmaceutical Company and is expected